This inventor holds 3 USPTO granted patents. Top assignees: Sanofi Biotechnology, Regeneron Pharmaceuticals, Inc.. Active years: 2018-2026.
Company Filing History:
3 out of 40 
2 out of 1,471 
Years Active: 2018-2026
Title: Brian Swanson: Innovator in Chronic Sinusitis Treatment
Introduction
Brian Swanson is a notable inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of chronic sinusitis. With a total of 3 patents, his work focuses on innovative methods to improve patient outcomes.
Latest Patents
Swanson's latest patents include groundbreaking methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist. The present invention provides methods for decreasing a nasal polyp score in a subject. These methods involve administering a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody or an antigen-binding fragment thereof. This innovative approach aims to enhance the quality of life for individuals suffering from this condition.
Career Highlights
Throughout his career, Brian Swanson has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Sanofi Biotechnology and Regeneron Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise and success as an inventor.
Collaborations
Swanson has collaborated with talented professionals in his field, including Leda Mannent and Gianluca Pirozzi. These partnerships have fostered a collaborative environment that encourages innovation and the development of effective treatments.
Conclusion
Brian Swanson's contributions to the treatment of chronic sinusitis through his patented methods demonstrate his commitment to advancing medical science. His work not only reflects his innovative spirit but also has the potential to significantly impact patient care.